SMNR
SMNR
US81686G1058
Semnur Pharmaceuticals Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
124.31M EUR
115.1M EUR
1.84B EUR
5.29B EUR
Enterprise Value
119.7M EUR
138.12M EUR
1.86B EUR
5.31B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
--
--
--
--
Price to Sales
--
--
--
--
Price to Book
--
--
--
--
EV/Revenue
--
--
--
--
EV/EBITDA
--
--
--
--
Price to FCF (P/FCF)
2.28x
--
--
--
EV/FCF
2.19x
--
--
--
FCF Yield
43.92%
-9.16%
-0.46%
-0.12%
ende